26 result(s)
-
1.
-
2.
Currax Pharmaceuticals LLC - 2022 CACP 25 - 2022-12-30
PatentsDisclosure - Adequacy or Deficiency of Description
Novelty - Novelty
Obviousness - Obviousness
-
3.
-
4.
-
5.
Kudos Pharmaceuticals Limited - 2022 CACP 22 - 2022-10-20
PatentsApplication for Patent - Double Patenting
Claims - Ambiguity or Indefiniteness (incomplete)
-
6.
Nakao, Kazuwa (Re) - 2022 CACP 21 - 2022-10-19
PatentsClaims - Ambiguity or Indefiniteness (incomplete)
Disclosure - Adequacy or Deficiency of Description
Novelty - Novelty
-
7.
Zakharian (Re) - 2022 CACP 20 - 2022-10-13
PatentsDisclosure - Adequacy or Deficiency of Description
Obviousness - Obviousness
Subject Matter (part 1) - Meaning of Art
Utility - Utility
-
8.
-
9.
Regents of the University of Minnesota - 2022 CACP 18 - 2022-08-16
PatentsObviousness - Obviousness
-
10.
BGC Partners, LP (Re) - 2022 CACP 17 - 2022-06-03
PatentsClaims - Ambiguity or Indefiniteness (incomplete)
Subject Matter (part 1) - Meaning of Art
Subject Matter (part 1) - Mere Plan
-
11.
Russell Investments Group, LLC (Re) - 2022 CACP 16 - 2022-05-30
PatentsSubject Matter (part 1) - Computer Programs
Subject Matter (part 1) - Meaning of Art
-
12.
BCE INC. (Re) - 2022 CACP 14 - 2022-05-17
PatentsClaims - Ambiguity or Indefiniteness (incomplete)
Obviousness - Obviousness
-
13.
BGC PARTNERS, INC. (Re) - 2022 CACP 15 - 2022-05-17
PatentsClaims - Ambiguity or Indefiniteness (incomplete)
Subject Matter (part 1) - Computer Programs
Subject Matter (part 1) - Meaning of Art
-
14.
Illinois Tool Works Inc. (Re) - 2022 CACP 13 - 2022-04-13
PatentsClaims - Ambiguity or Indefiniteness (incomplete)
Novelty - Novelty - Anticipation
Obviousness - Obviousness
Subject Matter (part 1) - Meaning of Art
Subject Matter (part 1) - Printed Matter
Utility - Utility
-
15.
Stukanov, Igor (Re) - 2022 CACP 12 - 2022-04-11
PatentsApplication for Patent - Amendment to - New Matter
Claims - Ambiguity or Indefiniteness (incomplete)
Disclosure - Adequacy or Deficiency of Description
Obviousness - Obviousness
-
16.
Ipsen Pharma S.A.S. (Re) - 2022 CACP 11 - 2022-04-01
PatentsDivision - Division
Novelty - Novelty
Obviousness - Obviousness
Subject Matter (part 1) - Professional or Artistic Skill
Subject Matter (part 2) - Living Things (Animals, plants, seeds, sperm) - Treatment of
-
17.
-
18.
Wasmund (Re) - 2022 CACP 9 - 2022-03-24
PatentsSubject Matter (part 1) - Computer Programs
Subject Matter (part 1) - Games
Subject Matter (part 1) - Meaning of Art
-
19.
BROLLEY, KATHERINE J. (Re) - 2022 CACP 8 - 2022-03-14
PatentsObviousness - Obviousness
Subject Matter (part 1) - Meaning of Art
-
20.
Novomatic AG (Re) - 2022 CACP 7 - 2022-02-24
PatentsSubject Matter (part 1) - Meaning of Art
Subject Matter (part 1) - Mere Plan
-
21.
The Dun and Bradstreet Corporation (Re) - 2022 CACP 6 - 2022-02-14
PatentsObviousness - Obviousness
Subject Matter (part 1) - Computer Programs
Subject Matter (part 1) - Meaning of Art
-
22.
Optuminsight, Inc (Re) - 2022 CACP 5 - 2022-02-03
PatentsSubject Matter (part 1) - Computer Programs
Subject Matter (part 1) - Meaning of Art
-
23.
BIO-RAD LABORATORIES, INC. (Re) - 2022 CACP 4 - 2022-01-27
PatentsClaims - Ambiguity or Indefiniteness (incomplete)
Disclosure - Adequacy or Deficiency of Description
Subject Matter (part 1) - Meaning of Art
-
24.
Merz Pharma GMBH & Co. KGAA (Re) - 2022 CACP 3 - 2022-01-27
PatentsClaims - Ambiguity or Indefiniteness (incomplete)
Subject Matter (part 1) - Professional or Artistic Skill
Subject Matter (part 2) - Living Things (Animals, plants, seeds, sperm) - Treatment of
Utility - Utility
-
25.
Biogen MA Inc. (Re) - 2022 CACP 2 - 2022-01-24
PatentsClaims - Excessive Width - Not Supported by Disclosure
Disclosure - Adequacy or Deficiency of Description
Subject Matter (part 1) - Professional or Artistic Skill
Subject Matter (part 2) - Living Things (Animals, plants, seeds, sperm) - Treatment of